|
ANKLE2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.797300E-04 |
| Normal-vs-Stage3 |
1.63224989080391E-12 |
| Normal-vs-Stage4 |
4.9617976394245E-11 |
| Stage1-vs-Stage2 |
2.757700E-02 |
| Stage1-vs-Stage3 |
8.051800E-01 |
| Stage1-vs-Stage4 |
8.426400E-01 |
| Stage2-vs-Stage3 |
1.949840E-02 |
| Stage2-vs-Stage4 |
2.934000E-02 |
| Stage3-vs-Stage4 |
9.808200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.3286999999983E-05 |
| Normal-vs-Asian |
2.66039967833365E-10 |
| Caucasian-vs-AfricanAmerican |
7.427800E-01 |
| Caucasian-vs-Asian |
3.297600E-01 |
| AfricanAmerican-vs-Asian |
7.273400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63857816204427E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.929200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.26189997235105E-09 |
| Normal-vs-Age(81-100Yrs) |
2.93950000007648E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.400800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.286480E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.665400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.668300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.060800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.453400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.166200E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
1.381810E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.23949999550643E-08 |
| Tall-VS-Other |
1.048990E-01 |
| Tall-VS-Normal |
1.80619963430217E-10 |
| Follicular-VS-Other |
1.206230E-01 |
| Follicular-VS-Normal |
3.416800E-01 |
| Other-VS-Normal |
6.169800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.14399625725537E-11 |
| Normal-vs-N1 |
1.83939530273847E-11 |
| N0-vs-N1 |
1.842480E-02 |
|
|
